CMS certification 363305
Nationwide Children's Hospital
700 Children's Drive, Columbus, OH 43205
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $2M
- 2020 $456,356
- 2021 $607,115
- 2022 $453,744
- 2023 $559,230
- 2024 $371,399
- 2025 $226,180
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $52,357 | 26 |
| Education | $50,543 | 78 |
| Grants | $45,550 | 19 |
| Space rental and facility fees | $36,297 | 30 |
| Speaking, teaching and other services | $5,700 | 6 |
| Consulting fees | $1,000 | 1 |
| Debt forgiveness | $321 | 4 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| KARL STORZ Endoscopy-America | $52,943 | 78 |
| Olympus Corporation of the Americas | $27,000 | 7 |
| Merit Medical Systems Inc | $19,780 | 2 |
| Linvatec Corporation | $17,440 | 1 |
| MED-EL Corporation | $17,400 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13,690 | 1 |
| Masimo Corporation | $9,121 | 21 |
| ClearPoint Neuro, Inc. | $8,176 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| PREEMIE: Study for Treatment of PDA in Premature Infants Merit Medical Systems Inc | $19,780 |
| LONG-TERM SAFETY AND TOLERABILITY OF TAK-881 IN SUBJECTS WITH PRIMARY IMMUNODEFICIENCY DISEASES (PIDD) Takeda Pharmaceuticals U.S.A., Inc. | $13,690 |
| EPIK-L1: a phase II/III double-blind, randomized, placebo-controlled study to assess the efficacy, safety and pharmacokinetics of alpelisib in pediat… Novartis Pharmaceuticals Corporation | $551 |
| ACP-101-302 ACADIA Pharmaceuticals Inc · NCT06420297 | $392 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Nationwide Children's Hospital
Does Nationwide Children's Hospital have an emergency room?
Yes. CMS lists emergency services at Nationwide Children's Hospital.
Does Nationwide Children's Hospital receive money from drug and device companies?
Drug and device makers reported $226,180 in payments to Nationwide Children's Hospital for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.